These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 174233)

  • 1. Effect of natural oestrogens on blood pressure and weight in postmenopausal women.
    Notelovitz M
    S Afr Med J; 1975 Dec; 49(55):2251-4. PubMed ID: 174233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of long-term oestrogen replacement therapy on glucose and lipid metabolism in postmenopausal women.
    Notelovitz M
    S Afr Med J; 1976 Nov; 50(50):2001-3. PubMed ID: 188205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of natural oestrogens on coagulation.
    Notelovitz M; Greig HB
    S Afr Med J; 1975 Jan; 49(4):101-5. PubMed ID: 164700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight.
    Utian WH
    Maturitas; 1978 Jun; 1(1):3-8. PubMed ID: 226840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence on blood pressure of oestrogen substitution therapy in the menopause.
    Eggertsen R
    Scand J Prim Health Care; 1987 Feb; 5(1):51-3. PubMed ID: 3035679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postmenopausal hormone substitution and its effects on the climacteric syndrome, body weight and blood pressure].
    Fritsch H; Fritsch W; Julius U; Rehak E; Wieczorek A; Hanefeld M
    Zentralbl Gynakol; 1997; 119(3):128-32. PubMed ID: 9173771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure changes: oestrogens in climacteric women.
    Wren BG; Routledge DA
    Med J Aust; 1981 Nov; 2(10):528-31. PubMed ID: 6275247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural estrogen and anti-thrombin III activity in postmenopausal women.
    Notelovitz M; Greig HB
    J Reprod Med; 1976 Feb; 16(2):87-90. PubMed ID: 176358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of type and dose of oestrogen on the blood pressure of post-menopausal women.
    Wren BG; Routledge AD
    Maturitas; 1983 Aug; 5(2):135-42. PubMed ID: 6314097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age at menopause on blood pressure in postmenopausal women.
    Izumi Y; Matsumoto K; Ozawa Y; Kasamaki Y; Shinndo A; Ohta M; Jumabay M; Nakayama T; Yokoyama E; Shimabukuro H; Kawamura H; Cheng Z; Ma Y; Mahmut M
    Am J Hypertens; 2007 Oct; 20(10):1045-50. PubMed ID: 17903686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension.
    Karalis I; Beevers G; Beevers M; Lip G
    Blood Press; 2005; 14(1):38-44. PubMed ID: 15823946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effect of conjugated oestrogens (USP) on glucose tolerance.
    Notelovitz M
    S Afr Med J; 1974 Dec; 48(62):2599-603. PubMed ID: 4374770
    [No Abstract]   [Full Text] [Related]  

  • 16. Nondipping status does not attenuate the conjugated estrogen-induced improvement in aortic stiffness in postmenopausal women with untreated hypertension.
    Tsioufis C; Tzioumis K; Dimitriadis K; Chatzis D; Skiadas I; Michailidis A; Toutouzas P; Kallikazaros I; Stefanadis C
    Am J Hypertens; 2005 May; 18(5 Pt 1):607-11. PubMed ID: 15882542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
    Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein[a].
    Mendoza S; Velazquez E; Osona A; Hamer T; Glueck CJ
    J Lab Clin Med; 1994 Jun; 123(6):837-41. PubMed ID: 8201261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement.
    Light KC; Grewen KM; Amico JA; Brownley KA; West SG; Hinderliter AL; Girdler SS
    Horm Behav; 2005 May; 47(5):540-8. PubMed ID: 15811355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of conjugated estrogens on coagulability in menopausal women.
    Stangel JJ; Innerfield I; Reyniak JV; Stone ML
    Obstet Gynecol; 1977 Mar; 49(3):314-6. PubMed ID: 190571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.